KATALYST Life Sciences SRL
The score of KATALYST Life Sciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +73 % Total assets +37 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →KATALYST Life Sciences's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −6,729 € | ||||
| Equity | 317,784 € | ||||
| Cash | 68,146 € | ||||
| EBITDA | −5,784 € | ||||
| Total assets | 320,875 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Aug 2026
- Year ended 31 Dec 2024filed on 05 Aug 2025
- Year ended 31 Dec 2023filed on 28 Sep 2024
- Year ended 31 Dec 2022filed on 08 Aug 2023
- Year ended 31 Dec 2021filed on 21 Aug 2022
KATALYST Life Sciences's financial analysis
- Solvency99.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of KATALYST Life Sciences
KATALYST Life Sciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.501.477
- VAT number
- BE0760501477
- Peppol
- Registered · 0208:0760501477 · as of 26 Oct 2026
- Legal form
- SRL
- Incorporated
- 23 Dec 2020
- Registered office
- 4122 Neupré
- Latest accounts
- 2025 · filed on 18 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
KATALYST Life Sciences (SRL) has been based in Neupré since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 6,729 € and equity of 317,784 €; its revenue is not published. Its solvency stands at 99.0%, above the median of its sector (58.2%).
Companies similar to KATALYST Life Sciences
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Praktijk Dokter Cooreman Etienne Research and experimental development on natural sciences and engineering Aalst · balance sheet 332,414 €
- PLT Analysis Research and experimental development on natural sciences and engineering Waterloo · balance sheet 305,968 €
- Sustaineer Research and experimental development on natural sciences and engineering Ghent · balance sheet 299,595 €
- Cabinet Medical Jacquerie Vandeponseele Research and experimental development on natural sciences and engineering Floreffe · balance sheet 358,921 €
- Lacto Research Research and experimental development on natural sciences and engineering Gembloux · balance sheet 360,033 €
- Dr. Lenaerts Patrick Research and experimental development on natural sciences and engineering Edegem · balance sheet 284,451 €
- CH-Chog Medical Research and experimental development on natural sciences and engineering Koekelberg · balance sheet 276,747 €
Frequently asked questions about KATALYST Life Sciences
What is the revenue of KATALYST Life Sciences?
KATALYST Life Sciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of KATALYST Life Sciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0760501477 for KATALYST Life Sciences, if the company is VAT-registered. Its company number (CBE) is 0760.501.477.
Where is the registered office of KATALYST Life Sciences?
According to the CBE register, the registered office of KATALYST Life Sciences is in 4122 Neupré.
What is the equity of KATALYST Life Sciences?
At the close of the 2025 financial year, the equity of KATALYST Life Sciences amounts to 317,784 €, a solvency of 99.0% of total assets.
Who manages KATALYST Life Sciences?
The register lists 1 active mandates at KATALYST Life Sciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of KATALYST Life Sciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →